A study published in the January edition of the Cureus Journal of Medical Science, has concluded that specific cannabinoids found in marijuana — namely CBD, CBC, CBN, CBG and CBGA, a plant-based toothpaste.
Arrays of antimicrobial agents are available in the market, such as chlorhexidine digluconate, which is the golden standard for an antimicrobial agent.
Along with the commercially available agents for reducing bacterial content of dental plaque, several natural herbal extracts, such as pomegranate, algae, triphala, tulsipatra, neem, aloe vera, and cinnamon, have been reported to be effective against dental plaque bacteria.
Similarly, cannabinoids extracted from cannabis has been reported to have potential antimicrobial properties against both gram-positive and gram-negative bacterial species.
A randomised controlled trial was conducted from January 2019 to March 2019 to assess the efficacy of cannabinoids in comparison to the efficacy of commercial oral care products in reducing the bacterial content of the dental plaque
This study found that cannabinoids are substantially effective in reducing the colony count of the bacterial strains of the dental plaque as compared to the well-established synthetic oral care products.
This study opened up the possibilities of developing personalised next-generation oral care products based on cannabinoids.
The study has some limitations, unfortunately, as researchers did not perform a statistical analysis on their data. And, as they point out, everyone’s mouth has a different microbiotic makeup — including differing types of bacteria — that makes drawing general conclusion more perilous.
While it’s true that high quality CBD products aren’t always cheap, the preventative properties (when it comes to many things) may possibly outweigh the costs of dealing with the resulting health issues that come from not practicing good self-care.
